The U.S. Medicaid program is likely paying far more than necessary for medications and not offering patients the most effective ones available, by ignoring international evidence-based lists of safe and effective medications, according to a new study by researchers at UCSF.
The U.S. Medicaid program is likely paying far more than necessary for medications and not offering patients the most effective ones available, by ignoring international evidence-based lists of safe and effective medications, according to a new study by researchers at UCSF.
“The United States has 51 different lists of medications that are paid for by Medicaid, and only a third of those medications consistently appear on the various lists,” said Lisa A. Bero, PhD, a professor in the UCSF School of Pharmacy. “This research suggests that Medicaid could save significant money and also provide safer and more effective medications for patients by using a more consistent approach to deciding which drugs will be covered.”
Full article on how the U.S. Medicaid program is ignoring international, evidence-based lists of safe and effective medications.
